K. Golebski Et Al. , "Induction of IL-10-producing type 2 innate lymphoid cells by allergen immunotherapy is associated with clinical response," IMMUNITY , vol.54, no.2, pp.291-314, 2021
Golebski, K. Et Al. 2021. Induction of IL-10-producing type 2 innate lymphoid cells by allergen immunotherapy is associated with clinical response. IMMUNITY , vol.54, no.2 , 291-314.
Golebski, K., Layhadi, J. A., Sahiner, Ü. M., Steveling-Klein, E. H., Lenormand, M. M., Li, R. C. Y., ... Bal, S. M.(2021). Induction of IL-10-producing type 2 innate lymphoid cells by allergen immunotherapy is associated with clinical response. IMMUNITY , vol.54, no.2, 291-314.
Golebski, Korneliusz Et Al. "Induction of IL-10-producing type 2 innate lymphoid cells by allergen immunotherapy is associated with clinical response," IMMUNITY , vol.54, no.2, 291-314, 2021
Golebski, Korneliusz Et Al. "Induction of IL-10-producing type 2 innate lymphoid cells by allergen immunotherapy is associated with clinical response." IMMUNITY , vol.54, no.2, pp.291-314, 2021
Golebski, K. Et Al. (2021) . "Induction of IL-10-producing type 2 innate lymphoid cells by allergen immunotherapy is associated with clinical response." IMMUNITY , vol.54, no.2, pp.291-314.
@article{article, author={Korneliusz Golebski Et Al. }, title={Induction of IL-10-producing type 2 innate lymphoid cells by allergen immunotherapy is associated with clinical response}, journal={IMMUNITY}, year=2021, pages={291-314} }